J Resnick - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J Resnick

Showing results (441-450 of 443) with videos related to

Pageof 45

Sort By:

You have reached the last page of results.This site can display upto 443 results.

Nature Communications|April 8, 2022

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Hengrui Liu, Sho Iketani, Arie Zask, et al.

Nature Communications|November 21, 2025

Multiplex neurodegeneration proteotoxicity platform reveals DNAJB6 promotes non-toxic FUS condensate gelation and inhibits neurotoxicitySamuel J Resnick, Seema Qamar, Pushya Krishna, et al.

The Journal of Urology|April 8, 2015

Gleason 6 Prostate Cancer: Translating Biology into Population HealthScott E Eggener, Ketan Badani, Daniel A Barocas, et al.

Pageof 45

Search research articles

Showing results (441-450 of 443) with videos related to

Sort By:

Pageof 45

You have reached the last page of results.This site can display upto 443 results.

Nature Communications|April 8, 2022

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Hengrui Liu, Sho Iketani, Arie Zask, et al.

Nature Communications|November 21, 2025

Multiplex neurodegeneration proteotoxicity platform reveals DNAJB6 promotes non-toxic FUS condensate gelation and inhibits neurotoxicitySamuel J Resnick, Seema Qamar, Pushya Krishna, et al.

The Journal of Urology|April 8, 2015

Gleason 6 Prostate Cancer: Translating Biology into Population HealthScott E Eggener, Ketan Badani, Daniel A Barocas, et al.

Pageof 45